AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02192697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASP8273
Description: Oral administration
Study NCT01426451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group tutoring program
Description: Academic in-class intervention that focuses on differentiated academic instruction and improved overall academic adjustment. In each classroom assigned to the tutorship intervention, two academic resource assistants will provide weekly in-class support to students for the same length of time than the drama workshop (75 minutes, once a week), with the teacher present in the classroom.
Study NCT01426451 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theatre workshops
Description: The theatre expression workshops will run for 12 weeks, with one 75-minute workshop per week. They will be incorporated into the regular class timetable and will be run by the two members of the intervention team who have training in theatre and psychology, and the homeroom teacher, whose level of direct involvement will increase gradually as he or she becomes familiar with the workshops.
Study NCT04268966 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brincidofovir
Study NCT03248804 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Soy group
Study NCT03248804 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Non-soy group
Study NCT02346422 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: MYDICAR Phase 1
Description: Single dose of MYDICAR
Study NCT02346422 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: MYDICAR Phase 2
Description: Single dose of MYDICAR
Study NCT02346422 — intervention group
Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Phase 2 only
Description: Single dose of placebo
Study NCT04342585 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Micronised vaginal progesterone
Description: A diary will be given to participants to ensure compliance.
Study NCT04342585 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal pessary
Description: The internal diameter size will be decided based on the clinical assessment of the cervix.
Study NCT03888079 — intervention group
Intervention type: DRUG
Intervention: Local anesthetic
Description: 1% or 2% lidocaine with 1:100,000 epinephrine, augmented by intravenous sedation and analgesia
Study NCT03888079 — intervention group
Intervention type: DRUG
Intervention: general anesthetic
Description: Endotracheal intubation, intravenous narcotic agents, and inhaled agents
Study NCT03238872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy
Study NCT03238872 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Study NCT01945242 — intervention group
Intervention type: DRUG
Intervention: Alogliptin
Description: Alogliptin tablets
Study NCT02813720 — intervention group
Intervention type: RADIATION
Intervention: HR-pQCT High resolution peripheral quantitative CT-scan
Description: HR-pQCT is a powerful device providing low dose irradiation already used in bone field.~It is a high resolution tool (voxel size=82µm) that the investigators adapted to look after the distal joint involved by onycholysis. An anteroposterior scout view is used to define the region of interest (ROI), which spanned from the top of the distal phalange to the distal part of the intermediate phalange in order to contain the distal joint of the target finger. Images are then analysed for erosions, osteophytes and volumetric bone mineral density.
Study NCT02318277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEDI4736
Description: MEDI4736 administered intravenously (IV) every two weeks (q2w)
Study NCT02318277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB024360
Description: INCB024360: Oral daily dosing
Study NCT04107363 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oropharyngeal aspiration before changing the position of the patient
Description: Patients in the experimental group underwent oropharyngeal aspiration prior to each position change in addition to routine nursing care (Endotracheal aspiration in case of indication and oropharyngeal aspiration in the follow-up; routine and non-routine position changes every 2 hours during the day and 4 hours during the night; oral care).~Patients in this group underwent oropharyngeal aspiration at least 9 times in 24 hours with a pressure of 100-120 mmHg for 10 seconds prior to routine (2 hours a day, 4 hours a night) and non-routine position changes. After the oropharyngeal aspiration was completed, the patient's position was changed.
Study NCT04107363 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group:
Description: The patients in the control group received routine nursing care in the unit. (Endotracheal aspiration in case of indication and oropharyngeal aspiration in the follow-up; routine and non-routine position changes every 2 hours during the day and 4 hours during the night; oral care).
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Sputum sample
Description: This is a collection of sputum (mucous) you cough up. Three morning samples will be collected at one time. Sputum will be collected at baseline, year 1, year 2 and year 5.
Study NCT05016180 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ropivacaine
Description: Before the induction of anesthesia, ropivacaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side
Study NCT05016180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: Before the induction of anesthesia, ropivacaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Pulmonary function tests
Description: A series of different breathing tests designed to measure lung function and to determine the presence or absence of chronic obstructive pulmonary disease will be performed at baseline.
Study NCT01475500 — intervention group
Intervention type: RADIATION
Intervention: Computerized tomography (CT) scan of the chest
Description: A CT scan uses x-rays to take detailed pictures of the chest. Performed at baseline, year 2 and year 5. If nodules are present, CT scans will be performed every 3 months for the first year of the study.
Study NCT01475500 — intervention group
Intervention type: OTHER
Intervention: Buccal epithelium collection
Description: Collect cells from the inside of the cheek. Samples will be collected at baseline and yearly to year 5.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Nasal brushings
Description: A cytobrush is used to remove cells on the surface of the inside of the nose. Samples will be collected at baseline and yearly to year 5.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Bronchoscopy
Description: A flexible tube with a light and a camera will be inserted through the nose or mouth, and into the lungs to look at the airway. Bronchial tissue will be obtained.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Bronchoalveolar lavage
Description: During a bronchoscopy, a flexible tube with a light and a camera is passed through the mouth or nose into the lungs and fluid is squirted into a small part of the lung and collected for examination. Bronchoscopies will be performed at baseline and at year 5.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Blood sample collection
Description: A venous blood sample will be collected for testing of biomarkers and other relevant tests. Blood will be taken at baseline and yearly to year 5.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Urine sample
Description: Urine will be collected for routine urine tests at baseline and yearly to year 5.
Study NCT01475500 — intervention group
Intervention type: PROCEDURE
Intervention: Questionnaire-data collection
Description: A questionnaire about the patient's health, medical, and smoking history. Administered at baseline and yearly to year 5. Data will be taken from patient interviews and from the medical record.
Study NCT04599257 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-899
Description: The device applicator combines high-intensity focused electromagnetic procedure and radiofrequency energy to induce visible muscle contractions along with heating of the subcutaneous fat.
Study NCT01118598 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tredaptive (nicotinic acid/ laropiprant)
Description: tablet of nicotinic acid 1000 mg/laropiprant 20 mg one tablet of for 4 weeks followed by two tablets od for 8 weeks
Study NCT01118598 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo tablet one a day for first 4 weeks followed by two a day for 8 weeks
Study NCT00585286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 10,600 nm fractional carbon dioxide laser system
Description: 1-3 laser treatments using 20-100 millijoules (mJ) with 100-400 microscopic treatment zones (MTZ)/cm2 per pass and total density of 600-1200 MTZ/cm2
Study NCT00967135 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: 150 mg oral dose of pregabalin twice daily for 5 consecutive days.
Study NCT00967135 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching oral placebo twice daily for 5 consecutive days.
Study NCT02502071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium bicarbonate
Description: All participants will receive 2 doses of 1950mg sodium bicarbonate
Study NCT02571244 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interview plus text message
Description: After discharge the experimental group has received extended care including a counseling session and text messages. The session provided basic information about smoking and successful quitting. The counselor has used motivational interview techniques to build coping skills with the goal of helping the participant build and implement a quit plan. The focus was to increase motivation to make quit attempt, including confidence building, medication use, and cessation planning. The session lasted approximately 30 minutes. Participants in the experimental arm were offered up to 30 text messages to help them to implement the quit plan discussed during the phone call. Patients motivated to quit in the next 30 days or those that had already quit have received 30 messages (2 per day) and patients unwilling to quit 16 (2 per day). The messages followed the self efficacy theory.
Study NCT02990143 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ologen
Description: Ologen® CM,a biodegradable scaffold matrix, induces a regenerative non-scarring wound healing process without using anti-fibrotic agents.
Study NCT03640026 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Tacrolimus will be initiated at 0.1 mg/kg/day in two separate 12-hour oral doses (capsules) for 14 days.
Study NCT01503957 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasya
Description: Thixotropic nasal spray suspension, 2 sprays in each nostril
Study NCT01503957 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Saline solution
Description: Nasal spray, 2 sprays in each nostril
Study NCT01261039 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: UV radiation
Description: Subjects in both groups will be exposed to light in a solar bed for approximately 10 minutes (depending on Fitzpatrick skin type test) on the first day, but only one of the solar beds wields ultraviolet rays. The other has a filter, which filters out the ultraviolet rays.
Study NCT01261039 — intervention group
Intervention type: RADIATION
Group type: SHAM_COMPARATOR
Intervention: UV radiation
Description: Subjects in both groups will be exposed to light in a solar bed for approximately 10 minutes (depending on Fitzpatrick skin type test) on the first day, but only one of the solar beds wields ultraviolet rays. The other has a filter, which filters out the ultraviolet rays.
Study NCT04125186 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Baseline EpiNP survey
Description: The survey takes approximately 20 to 30 minutes to complete, and consists of the following: Short Form Health Survey version 2.0 (SF-12v2.0); Lower Urinary Tract Symptoms (LUTS) Tool; Patient Perception of Bladder Condition (PPBC); Self-report Medical History and Current Medication Form; Nocturia Impact Diary (NID); Disease-Specific Healthcare-Seeking Behavior and Treatment; Epworth Sleepiness Questionnaire (ESS); Patient Reported Outcome Measurement Information System Fatigue-Short Form version 1.0 (PROMIS F-SFv1.0); Patient Health Questionnaire (PHQ-8); Work Productivity and Activity Index (WPAI-SHP); Sexual health questions; lifestyle and sociodemographic questions; additionally, only men will complete the International Prostate Symptom Score (IPSS).
Study NCT04125186 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Bladder diary
Description: It consists of four components: measurement of waist and neck circumference, daily voiding diary (to assess voiding patterns, including frequency, volume, associated urgency, and incontinence episodes over a 24-hour period), NID (to assess nocturia impact), and assessment of morning sleepiness for 3 consecutive days and nights (including the morning of the fourth day).
Study NCT04125186 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Testing of EpiNP baseline survey, bladder diary and a qualitative interview
Description: This part briefly reviews the usability of the EpiNP survey and bladder diary. The feedback obtained after qualitative interview will be used to refine and finalize the instructions sent to the participants in the main part.
Study NCT04125186 — intervention group
Intervention type: OTHER
Intervention: No other intervention
Description: No other intervention
Study NCT03418753 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EyeBOX for ICP
Description: non-invasive ICP Score algorithm using eye-tracking data from the EyeBOX(TM) device, which tracks the movement of the pupils over time
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2189265
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glimepiride
Study NCT01075282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glimepiride
Study NCT03899935 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopy
Description: Laparoscopy for endometriosis
Study NCT02630797 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Blueberry Baseline
Description: Before the study beginning, eligible participants will receive a radioactive tracer, Ca-41, by iv infusion. A total of 150 days will be required for the equilibration of tracer in the body i.e. elimination from soft tissue and deposition in the bone. After equilibration, a baseline period of 42 days will occur, during which no blueberry products will be provided.
Study NCT02630797 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Blueberry Low
Description: One food or beverage product containing freeze-dried blueberry powder equivalent to 0.75 cups of fresh blueberries will be provided daily for 42 days.
Study NCT02630797 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Blueberry Medium
Description: Two food or beverage products containing freeze-dried blueberry powder equivalent to 1.5 cups of fresh blueberries will be provided daily for 42 days.
Study NCT02630797 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Blueberry High
Description: Four food or beverage products containing freeze-dried blueberry powder equivalent to 3 cups of fresh blueberries will be provided daily for 42 days.
Study NCT03556813 — intervention group
Intervention type: OTHER
Intervention: survey
Description: non-inferiority study, randomized, blind, excluding health product, with no risk or constraint, in which all the acts are performed in the usual way and do not modify the patient's management.
Study NCT03302832 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Description: Physical therapy includes both the in-person and home-based interventions prescribed for each individual participant in order to maximize overall patient outcomes including: ambulation, range of motion, strength, functional activities, pain, swelling, balance, patient safety, and other items within the scope of physical therapy practice.
Study NCT02460380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: Women allocated to vitamin D arm received one capsule 50.000 IU of vitamin D3 once weekly for eight weeks.
Study NCT02460380 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Women in the placebo arm received once capsule of placebo once weekly for eight weeks
Study NCT01146444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UV A and B irradiation
Description: UV irradiation
Study NCT02358395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBI608
Description: Administered continuously twice daily with doses separated by 9-15 hours.
Study NCT03302832 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Therapy
Description: Physical therapy includes both the in-person and home-based interventions prescribed for each individual participant in order to maximize overall patient outcomes including: ambulation, range of motion, strength, functional activities, pain, swelling, balance, patient safety, and other items within the scope of physical therapy practice.
Study NCT03302832 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: In-home Exercise Equipment
Description: The in-home exercise component of the study will supplement physical therapy services. This exercise equipment will be utilized daily for up to 90 minutes as guided by the healthcare team
Study NCT04332445 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid Gel
Description: Health care product - to be apllied on the subject's skin
Study NCT01058213 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: Supervised training will be performed on a cable exercise system (Body Solid, Forest Park, IL) using six exercises that involve concentric and eccentric muscle actions: leg press, knee flexion, knee extension, calf raise, hip adduction, hip abduction. Subjects will perform the lower extremity exercises under the direct supervision of an exercise specialist three times per week. Subjects will perform 2 sets of 8-10 repetitions at 70% of their maximum strength for 2 weeks, then will perform 2 sets of 8-10 repetitions at 80% of their maximal strength for 2 weeks, and for the next 4 weeks they will perform 3 sets of 8-10 repetitions at 80% of their maximal strength. Sets will be separated by at least a 2-3 minute rest period for multiple-joint exercises and at least 1-2 minutes for single-joint exercises. A moderate velocity of muscle contraction (\~1-2 seconds for concentric and eccentric contraction) will be used.
Study NCT01058213 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Supervised training will be performed on a cable exercise system (Body Solid, Forest Park, IL) using six exercises that involve concentric and eccentric muscle actions: leg press, knee flexion, knee extension, calf raise, hip adduction, hip abduction. Subjects will perform the lower extremity exercises under the direct supervision of an exercise specialist three times per week. Subjects will perform 2 sets of 8-10 repetitions at 70% of their maximum strength for 2 weeks, then will perform 2 sets of 8-10 repetitions at 80% of their maximal strength for 2 weeks, and for the next 4 weeks they will perform 3 sets of 8-10 repetitions at 80% of their maximal strength. Sets will be separated by at least a 2-3 minute rest period for multiple-joint exercises and at least 1-2 minutes for single-joint exercises. A moderate velocity of muscle contraction (\~1-2 seconds for concentric and eccentric contraction) will be used.
Study NCT01058213 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic training
Description: Cycle ergometry training will be performed in the lab on a stationary cycle ergometer, calibrated with a 4 kg weight (Monark 828E, Varberg, Sweden). Initial work rate will be 50% of peak work rate (PWR) as tolerated and will be evaluated weekly with progressive increases targeted to achieve the highest work rate tolerated for 3-5 minutes{: wks 1-2 50% PWR, wks 3-4 60% PWR, wks 5-6 70% PWR, wks 7-8 80% PWR}. An interval training protocol will be used with subjects performing four work sets of five minutes duration separated by rest intervals of unloaded cycling lasting 2-4 minutes.
Study NCT01058213 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic training
Description: Cycle ergometry training will be performed in the lab on a stationary cycle ergometer, calibrated with a 4 kg weight (Monark 828E, Varberg, Sweden). Initial work rate will be 50% of peak work rate (PWR) as tolerated and will be evaluated weekly with progressive increases targeted to achieve the highest work rate tolerated for 3-5 minutes{: wks 1-2 50% PWR, wks 3-4 60% PWR, wks 5-6 70% PWR, wks 7-8 80% PWR}. An interval training protocol will be used with subjects performing four work sets of five minutes duration separated by rest intervals of unloaded cycling lasting 2-4 minutes.
Study NCT04081558 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic patient reported outcomes tool
Description: Electronic patient reported outcomes
Study NCT02358395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Sorafenib 400 mg twice daily (800 mg total daily dose).